Evidence map›Paper›PMID 40881747›Full record

ReviewWorld journal of transplantation2025

Extracorporeal therapies for post-liver transplant recipient: The road less traveled.

Anant Vikram Pachisia, Deepak Govil, K N Jagadeesh, Sweta J Patel, Rahul Harne, Divya Pal, Pooja Tyagi, Swagat Pattajoshi, Keerti Brar, Parimal Patel and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anant Vikram PachisiaInstitute of Critical Care and Anesthesiology, Medanta-The Medicity, Gurugram 122001, Haryana, India.
Deepak GovilInstitute of Critical Care and Anesthesiology, Medanta-The Medicity, Gurugram 122001, Haryana, India. drdeepak_govil@yahoo.co.in.
K N JagadeeshInstitute of Critical Care and Anesthesiology, Medanta-The Medicity, Gurugram 122001, Haryana, India.
Sweta J PatelInstitute of Critical Care and Anesthesiology, Medanta-The Medicity, Gurugram 122001, Haryana, India.
Rahul HarneInstitute of Critical Care and Anesthesiology, Medanta-The Medicity, Gurugram 122001, Haryana, India.
Divya PalInstitute of Critical Care and Anesthesiology, Medanta-The Medicity, Gurugram 122001, Haryana, India.
Pooja TyagiInstitute of Critical Care and Anesthesiology, Medanta-The Medicity, Gurugram 122001, Haryana, India.
Swagat PattajoshiInstitute of Critical Care and Anesthesiology, Medanta-The Medicity, Gurugram 122001, Haryana, India.
Keerti BrarInstitute of Critical Care and Anesthesiology, Medanta-The Medicity, Gurugram 122001, Haryana, India.
Parimal PatelInstitute of Critical Care and Anesthesiology, Medanta-The Medicity, Gurugram 122001, Haryana, India.
Ronak ZatakiyaInstitute of Critical Care and Anesthesiology, Medanta-The Medicity, Gurugram 122001, Haryana, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracorporeal therapies have a definite role in patients with acute liver failure, acute on-chronic liver failure, and progressive chronic liver disease. They act as a bridge-to-transplant in these patients. With the increasing success of liver transplantation, the immediate postoperative complication spectrum continues to expand. Extracorporeal therapies can play an important role in managing these complications. However, the literature on extracorporeal therapies in the post-liver transplant period is limited. This review article discussed various extracorporeal therapies that are still evolving or marred by limited evidence but can improve patient outcomes. These extracorporeal therapies can be divided into two subgroups: (1) Therapies for infective complications. Endotoxin and cytokine adsorption columns; and (2) Therapies for noninfective complications like small for size syndrome, primary allograft nonfunction, early allograft dysfunction, hyperacute rejection, hepatopulmonary syndrome,

Indexed as

Critical careCytokine adsorptionExtracorporeal membrane oxygenationExtracorporeal therapiesIntensive care unitLiver transplantMolecular adsorbent recirculation systemPolymyxin B hemoperfusionTherapeutic plasma exchange

Identifiers

PMID40881747
PMCPMC12038603

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.